ангиотензин II 和心血管疾病:平衡致病性和保护性途径
1Academic Unit of Mental Health and Clinical Neurosciences, University of Nottingham, Nottingham NG7 2UH, UK.
Current issues in molecular biology
|July 29, 2025
概括
氨酸- ангиотензин- алдостерон系统 (RAAS) 影响血压和衰老. 虽然血管酶二可以损害血管,但它也提供保护,突出其在心血管健康和疾病中的复杂作用.
科学领域:
- 心血管科学 心血管科学
- 内分泌学 在内分泌学.
- 衰老研究研究 衰老研究
背景情况:
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 调节血压和液体平衡.
- ангиотензин II 是一个关键的RAAS成分,它与AT1R和AT2R受体结合.
- RAAS的失调有助于心血管疾病和衰老.
研究的目的:
- 审查RAAS及其组成部分.
- 探索血管病理和衰老中血管激素II的双重作用.
- 讨论针对RAAS的治疗策略.
主要方法:
- 关于RAAS的文献综述.
- 通过AT1R和AT2R对血管素II的影响的分析.
- 检查ACE和ACE2在心血管保护中的作用.
主要成果:
- AT1R激活促进血管收缩,氧化应激和动脉样硬化,从而导致衰老.
- 激活AT2R会诱导血管扩张,并保护血管疾病.
- 血管酶的ACE2介导转化为心血管提供了好处.
结论:
- ангиотензинII具有双重作用,通过AT1R促进疾病,但通过AT2R和ACE2通路提供保护.
- 了解这些双重作用对于开发有效的抗高血压和抗衰老疗法至关重要.
- 准RAAS组件为管理心血管病理和与年龄相关的衰退提供了潜力.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
888
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
888
Hypertension II: Pathophysiology
79
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
79
Antihypertensive Drugs: Angiotensin II Receptor Blockers
927
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
927
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
Antihypertensive Drugs: Direct Renin Inhibitors
827
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
827
Heart Failure II: Pathophysiology
44
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
44


